Industry News
Colorectal cancer patients need colonoscopy after cancer resection
2/17/2016
It is critically important that colorectal cancer patients undergo colonoscopy after surgery to ensure that they do not have a second colon cancer, and to find and remove any additional polyps.
A new study, published by Nature Scientific Report, presented a revolutionary method to isolate 100% pure tumor and stromal cell populations from minute formalin fixed, paraffin embedded (FFPE)...
Colorectal cancer patients need colonoscopy after cancer resection
2/17/2016
It is critically important that colorectal cancer patients undergo colonoscopy after surgery to ensure that they do not have a second colon cancer, and to find and remove any additional polyps.
First-in-class drug ONC201 shows potential for some blood cancers
2/17/2016
ONC201, an anti-cancer drug that triggers cell death in various tumor types, may have clinical potential for some blood cancers including mantel cell lymphoma (MCL) and acute myeloid leukemia...
Some chemotherapy drugs may improve tumor response to immune checkpoint therapy
2/17/2016
The use of certain traditional chemotherapy drugs may expand the number of tumors that respond to one of today's most promising cancer therapies - immune checkpoint blockade.
Injuries and other health concerns are more common in older people after certain cancer surgeries
2/17/2016
Older people who undergo cancer surgery are more likely than their younger counterparts to experience injuries and health issues such as falling down, breaking bones, dehydration, bed sores...
First-in-class drug ONC201 shows potential for some blood cancers
2/17/2016
ONC201, an anti-cancer drug that triggers cell death in various tumor types, may have clinical potential for some blood cancers including mantel cell lymphoma (MCL) and acute myeloid leukemia...
Some chemotherapy drugs may improve tumor response to immune checkpoint therapy
2/17/2016
The use of certain traditional chemotherapy drugs may expand the number of tumors that respond to one of today's most promising cancer therapies - immune checkpoint blockade.
MD Anderson researchers propose new staging for HPV-related oropharyngeal cancer
2/17/2016
Current staging system is inadequate; for the first time, research proves that staging based on nasopharyngeal 'N' categories offers more predictive value.
What factors affect non-compliance with endocrine therapy among young women with breast cancer?
2/17/2016
A new study from Harvard Medical School of young women with hormone receptor-positive (HR+) breast cancer showed that more than half did not believe endocrine therapy was essential, even though it...